Getting your Trinity Audio player ready...

Peraso Inc. (NASDAQ: PRSO) Rides Military AI Boom as Defense Spending Surges – More Stocks Inside

As global defense spending surges, investors are turning their attention to AI-driven military technologies, fueling demand for secure, high-speed communication systemsPeraso Inc. (NASDAQ: PRSO) is emerging as a key player in this evolving sector, leveraging its millimeter wave (mmWave) technology to provide low-latency, interference-free communications, critical for military drone surveillance, real-time battlefield intelligence, and defense networking. With defense agencies prioritizing next-gen connectivity solutionsPRSO stands poised for potential military contracts and strategic partnerships. Also AI-powered biotech stocks gaining attention, mentioned inside this article.

Financial & Market Indicators:

  • Defense Spending Growth: The U.S. defense budget exceeded $850 billion in 2024, with AI-driven military projects receiving increased funding for advanced communication and security solutions—a sector where Peraso’s mmWave technology thrives.
  • Comparison to GSI Technology (NASDAQ: GSIT): GSIT, which specializes in AI-powered military computing, saw a 43% surge after securing a U.S. Army contract, underscoring the market potential for similar small-cap stocks like PRSO.
  • Potential for Military Contracts: PRSO’s mmWave solutions align with government and defense agency needs, making it a top contender for future defense technology contracts.

Why PRSO is a Smart Play for Defense Investors:

  • High-Security CommunicationPRSO’s mmWave technology is resistant to jamming and interference, making it ideal for military drone operations and secure battlefield intelligence.
  • Growing Industry Momentum: As military AI adoption accelerates, investors are seeking defense-tech crossover stocks, positioning PRSO as a rare, publicly traded player in this space.
  • Small-Cap Growth PotentialUnlike large-cap defense stocks, PRSO remains undervalued, giving early investors a chance to capitalize on its emerging role in AI-powered defense technology.

Additional Market Movers to Watch:

  • Kairos Pharma (NYSE: KAPA) is pioneering immune-suppression resistant cancer therapeutics, with a pipeline targeting prostate cancer, lung cancer, breast cancer, and glioblastoma.
  • Quantum BioPharma (NASDAQ: QNTM) confirmed its supplement unbuzzd™ accelerates alcohol metabolism, reducing BAC by over 40% in 30 minutes, improving alertness and cognitive function.
  • Evaxion Biotech (NASDAQ: EVAX) closed a $10.8 million public offering to advance its AI-powered cancer immunotherapy candidates, backed by Merck’s MSD Global Health Innovation Fund.
  • Invivyd (NASDAQ: IVVD) reported positive Phase 1/2 clinical data for VYD2311, a long-acting alternative to COVID-19 vaccines, with 17x greater neutralization potency than pemivibart.
  • ·        CS Diagnostics Corp. (OTCQB: CSDX) launches MEDUSA, a next-gen smart disinfectant with up to 10 days of surface protection, EU and UAE approvals, pending U.S. clearance, and a projected $80M revenue by 2025, aiming for 10% of the $8.37B global disinfectant market.

As defense budgets rise and AI-driven military tech advances, PRSO’s mmWave solutions present a strong investment opportunity in the defense-tech sector. Meanwhile, AI-powered biotech stocks like KAPA, QNTM and EVAX, are gaining traction in next-gen immunotherapy and antibody treatments, highlighting AI’s impact on healthcare. With potential military contracts and industry momentumPRSO is poised for breakout growth, making it a top watchlist stock alongside KAPA, QNTM, IVVD, EVAX, CSDX and GSIT.